Conventional Hemangiopericytoma: Modern Analysis of Outcome

BACKGROUND. Hemangiopericytoma (HPC) is a rare vascular tumor, and pathologic distinction from synovial sarcoma and solitary fibrous tumor is a significant problem due to shared histologic features. In the current report the authors defined the clinical behavior and prognosis for patients with HPC....

Full description

Saved in:
Bibliographic Details
Main Authors: Espat, N. J., Lewis, J. J., Leung, Denis H. Y., Woodruff, J. M., Antonescu, C., Shia, J.
Format: text
Language:English
Published: Institutional Knowledge at Singapore Management University 2002
Subjects:
Online Access:https://ink.library.smu.edu.sg/soe_research/40
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Singapore Management University
Language: English
id sg-smu-ink.soe_research-1039
record_format dspace
spelling sg-smu-ink.soe_research-10392010-09-23T05:48:03Z Conventional Hemangiopericytoma: Modern Analysis of Outcome Espat, N. J. Lewis, J. J. Leung, Denis H. Y. Woodruff, J. M. Antonescu, C. Shia, J. BACKGROUND. Hemangiopericytoma (HPC) is a rare vascular tumor, and pathologic distinction from synovial sarcoma and solitary fibrous tumor is a significant problem due to shared histologic features. In the current report the authors defined the clinical behavior and prognosis for patients with HPC. METHODS. Between July 1982 and February 1998, 62 patients with a diagnosis of primary, recurrent, or metastatic HPC were identified from a prospectively maintained database. The pathology of all cases for which material was available (57 cases) was re-reviewed for histologic confirmation of the HPC diagnosis. Using strict pathologic criteria, including immunohistochemistry and electron microscopy, tumors from 25 of 57 patients qualified for the diagnosis of conventional hemangiopericytoma; those tumors formed the basis of the current report. Survival was determined by the Kaplan-Meier method. RESULTS. At the time of initial presentation, 19 patients had primary tumors, 3 had locally recurrent disease, and 3 had metastatic disease. The most frequent anatomic sites for HPC were the extremities, the pelvis, and the head and neck, accounting for 80% of the total cases. The median followup (n = 25) was 49 months (range, 1 to 160 months). The two and five year overall survival rates (n = 25) were 93% and 86% respectively. The disease-specific survival was 86% at last followup. Patients undergoing complete resection (n = 16) showed a 100% median survival at 60 months. CONCLUSIONS. At present, complete tumor resection for patients with conventional I IPC is recommended. However, considering the favorable outcome in this disease, the authors caution against performing operations that may potentially cause loss of function or are limb threatening. 2002-01-01T08:00:00Z text https://ink.library.smu.edu.sg/soe_research/40 info:doi/10.1002/cncr.10867 Research Collection School Of Economics eng Institutional Knowledge at Singapore Management University Econometrics Medicine and Health Sciences
institution Singapore Management University
building SMU Libraries
continent Asia
country Singapore
Singapore
content_provider SMU Libraries
collection InK@SMU
language English
topic Econometrics
Medicine and Health Sciences
spellingShingle Econometrics
Medicine and Health Sciences
Espat, N. J.
Lewis, J. J.
Leung, Denis H. Y.
Woodruff, J. M.
Antonescu, C.
Shia, J.
Conventional Hemangiopericytoma: Modern Analysis of Outcome
description BACKGROUND. Hemangiopericytoma (HPC) is a rare vascular tumor, and pathologic distinction from synovial sarcoma and solitary fibrous tumor is a significant problem due to shared histologic features. In the current report the authors defined the clinical behavior and prognosis for patients with HPC. METHODS. Between July 1982 and February 1998, 62 patients with a diagnosis of primary, recurrent, or metastatic HPC were identified from a prospectively maintained database. The pathology of all cases for which material was available (57 cases) was re-reviewed for histologic confirmation of the HPC diagnosis. Using strict pathologic criteria, including immunohistochemistry and electron microscopy, tumors from 25 of 57 patients qualified for the diagnosis of conventional hemangiopericytoma; those tumors formed the basis of the current report. Survival was determined by the Kaplan-Meier method. RESULTS. At the time of initial presentation, 19 patients had primary tumors, 3 had locally recurrent disease, and 3 had metastatic disease. The most frequent anatomic sites for HPC were the extremities, the pelvis, and the head and neck, accounting for 80% of the total cases. The median followup (n = 25) was 49 months (range, 1 to 160 months). The two and five year overall survival rates (n = 25) were 93% and 86% respectively. The disease-specific survival was 86% at last followup. Patients undergoing complete resection (n = 16) showed a 100% median survival at 60 months. CONCLUSIONS. At present, complete tumor resection for patients with conventional I IPC is recommended. However, considering the favorable outcome in this disease, the authors caution against performing operations that may potentially cause loss of function or are limb threatening.
format text
author Espat, N. J.
Lewis, J. J.
Leung, Denis H. Y.
Woodruff, J. M.
Antonescu, C.
Shia, J.
author_facet Espat, N. J.
Lewis, J. J.
Leung, Denis H. Y.
Woodruff, J. M.
Antonescu, C.
Shia, J.
author_sort Espat, N. J.
title Conventional Hemangiopericytoma: Modern Analysis of Outcome
title_short Conventional Hemangiopericytoma: Modern Analysis of Outcome
title_full Conventional Hemangiopericytoma: Modern Analysis of Outcome
title_fullStr Conventional Hemangiopericytoma: Modern Analysis of Outcome
title_full_unstemmed Conventional Hemangiopericytoma: Modern Analysis of Outcome
title_sort conventional hemangiopericytoma: modern analysis of outcome
publisher Institutional Knowledge at Singapore Management University
publishDate 2002
url https://ink.library.smu.edu.sg/soe_research/40
_version_ 1770569013182595072